Current Pharmacological Treatments in Type 1 Diabetes and Patient Tolerability against New Generation Medicines
<p id="p1">Type 1 diabetes mellitus (T1D) is an autoimmune condition characterized by insulin deficiency due to pancreatic beta-cell destruction. The global incidence of T1D has been increasing and reached 12 million patients in 2021. Diabetes is expected to rank third place, following cardiovascula...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2024
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1199206 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!